2m 2m 2m 2m 2m 2m 2m
SANA BIOTECH (SANA)
NASDAQ
$3.58-$0.06 (-1.79%)
Price as of Jul 14, 2026 5:51 AM EDT- $1.0BMarket Cap
- -13.74%1-Year Change
- BiotechnologyIndustry
SANA BIOTECH (SANA)
$3.58-$0.06 (-1.79%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -132.0M -39.34% | -217.6M -19.07% | -268.8M -5.97% | -285.9M +14.99% | |
Depreciation and Amortization Expense | 0 N/A | 0 N/A | 0 -100.00% | 15.6M +41.15% | |
Total Operating Expenses | 250.3M -8.21% | 272.7M -6.97% | 293.1M +7.55% | 272.6M -23.63% | |
Operating Profit | -250.3M -8.21% | -272.7M -6.97% | -293.1M +7.55% | -272.6M -23.63% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 2.3M +151.14% | -4.5M +8,567.31% | -52,000 -92.28% | -674,000 -320.98% | |
Income before Taxes | -250.3M -8.21% | -272.7M -6.97% | -293.1M +7.55% | -272.6M -23.42% | |
Income Taxes | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | 44.6M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -244.2M -8.47% | -266.8M -5.82% | -283.3M +5.11% | -269.5M -24.29% | |
Net Income from Continuing Operations Applicable to Common | -244.2M -8.47% | -266.8M -5.82% | -283.3M +5.11% | -269.5M -24.29% | |
Basic EPS and Net Income | -0.96 -17.24% | -1.16 -20.55% | -1.46 +2.10% | -1.43 -33.18% | |
Diluted EPS and Net Income | -0.96 -17.24% | -1.16 -20.55% | -1.46 +2.10% | -1.43 -33.18% | |
Basic Weighted Average Shares | 253.2M +9.68% | 230.9M +18.69% | 194.5M +3.29% | 188.3M +13.17% | |
Diluted Weighted Average Shares | 253.2M +9.68% | 230.9M +18.69% | 194.5M +3.29% | 188.3M +13.17% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 71.9M -43.66% | 127.6M -4.46% | 133.5M -24.47% | 176.8M -30.14% | |
Short-Term Investments | 66.5M +166.78% | 24.9M -65.22% | 71.7M -71.00% | 247.2M -17.04% | |
Cash and Cash Equivalents and Short-Term Investments | 138.4M -9.26% | 152.5M -25.68% | 205.2M -51.60% | 424.0M -23.06% | |
Total Current Assets | 148.7M -7.54% | 160.8M -24.69% | 213.5M -51.96% | 444.4M -20.37% | |
Accumulated Depreciation | 54.8M +1.09% | 54.2M +29.67% | 41.8M +22.94% | 34.0M +80.98% | |
Property and Plant and Equipment and Net | 26.9M -65.20% | 77.3M +9.36% | 70.7M +5.64% | 66.9M +2.22% | |
Total Long-Term Assets | 3.2M -38.04% | 5.1M -19.61% | 6.4M +38.51% | 4.6M -8.02% | |
Total Assets | 416.9M -16.79% | 501.0M -11.37% | 565.3M -31.29% | 822.7M -27.15% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 78.7M +73.28% | 45.4M -29.55% | 64.5M -42.17% | 111.5M +12.36% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 10.6M +7.11% | 9.9M -89.11% | 90.9M -5.17% | 95.9M +17,651.85% | |
Total Liabilities | 256.0M +2.19% | 250.5M -9.82% | 277.8M -14.10% | 323.4M -19.33% | |
Retained Earnings | -1.8B +15.21% | -1.6B +19.94% | -1.3B +26.85% | -1.1B +34.31% | |
Total Stockholders Equity | 160.9M -35.78% | 250.5M -12.87% | 287.5M -42.42% | 499.3M -31.46% | |
Total Shares Outstanding | 266.7M +19.12% | 223.9M +13.17% | 197.9M +3.58% | 191.0M +3.29% | |
Cash Flow | |||||
Cash from Operating Activities | -143.8M -35.55% | -223.2M -12.00% | -253.6M -12.57% | -290.1M +15.53% | |
Capital Expenditures | 938,000 -97.19% | 33.4M +66.88% | 20.0M -4.04% | 20.9M -30.09% | |
Cash from Investing Activities | -40.2M -330.55% | 17.5M -89.85% | 172.0M -18.31% | 210.6M +185.66% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 128.7M -35.55% | 199.7M +531.20% | 31.6M +544.13% | 4.9M -99.22% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -53.20% +6.33% | -50.03% +22.59% | -40.81% +47.83% | -27.61% N/A | |
Return on Equity | -118.70% +19.70% | -99.17% +37.73% | -72.00% +64.03% | -43.90% N/A | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 1.89 -46.65% | 3.54 +6.90% | 3.31 -16.93% | 3.99 N/A | |
Cash Ratio | 0.91 -67.49% | 2.81 +35.62% | 2.07 +30.60% | 1.59 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow